A novel lncRNA ABCE1-5 regulates pulmonary fibrosis by targeting KRT14
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00374.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Shuwei Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Respiratory Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: | Natural Science Foundation of Beijing Municipality (), MOST | National Key Research and Development Program of China (NKPs), CAMS Insitute of Respiratory Medicine Grant for Young Scholars.
Abstract (Originalsprache)
In the present study, our data first reveal that a novel lncRNA ABCE1-5 could inhibit pulmonary fibrosis through interacting with krt14 and negative regulation of its expression, and indicated ABCE1-5 also regulates the phosphorylation of mTOR and Akt, thus acting on extracellular matrix remodeling in lung fibrosis procession. These results suggest that novel molecules within the ABCE1-5-krt14-mTOR axis may serve as potential candidates for clinical application in IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Respiratory Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China.
- National Clinical Research Center for Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China.
- Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China.
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China.
- Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, People's Republic of China.
- Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Ye Cui, Huaping Dai
Förderung
- | Natural Science Foundation of Beijing Municipality ()
- MOST | National Key Research and Development Program of China (NKPs)
- CAMS Insitute of Respiratory Medicine Grant for Young Scholars
- 北京市科学技术委员会 | Natural Science Foundation of Beijing Municipality
Zitieren
APA
Gao, S., Wei, Y., Li, C., Xie, B., Zhang, X., Cui, Y., & Dai, H. (2025). A novel lncRNA ABCE1-5 regulates pulmonary fibrosis by targeting KRT14. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00374.2024
Vancouver
Gao S, Wei Y, Li C, Xie B, Zhang X, Cui Y, et al. A novel lncRNA ABCE1-5 regulates pulmonary fibrosis by targeting KRT14. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00374.2024
BibTeX
@article{Gao2025,
author = {Gao, Shuwei and Wei, Yanqiu and Li, Chen and Xie, Bingbing and Zhang, Xinran and Cui, Ye and Dai, Huaping},
title = {A novel lncRNA ABCE1-5 regulates pulmonary fibrosis by targeting KRT14},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00374.2024}
}
EUVIMED